We are live on ! Find out more
EW icon

Edwards Lifesciences

658 hedge funds and large institutions have $15.9B invested in Edwards Lifesciences in 2016 Q1 according to their latest regulatory filings, with 102 funds opening new positions, 220 increasing their positions, 243 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more first-time investments, than exits

New positions opened: 102 | Existing positions closed: 39

52% more call options, than puts

Call options by funds: $175M | Put options by funds: $115M

9% more funds holding

Funds holding: 604658 (+54)

6% more ownership

Funds ownership: 254.73%260.73% (+6%)

0% more funds holding in top 10

Funds holding in top 10: 1616 (0)

9% less repeat investments, than reductions

Existing positions increased: 220 | Existing positions reduced: 243

6% less capital invested

Capital invested by funds: $16.9B → $15.9B (-$1.06B)

Holders
658
Holders Change
+54
Holders Change %
+8.94%
% of All Funds
17.53%
Holding in Top 10
16
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.43%
New
102
Increased
220
Reduced
243
Closed
39
Calls
$175M
Puts
$115M
Net Calls
+$59.8M
Net Calls Change
+$20.1M
Name Holding Trade Value Shares
Change
Change in
Stake
FMBTD
376
First Midwest Bank Trust Division
Illinois
$1.18M +$774K +28,035 +234%
Janney Montgomery Scott
377
Janney Montgomery Scott
Pennsylvania
$1.16M +$692K +25,080 +173%
D.E. Shaw & Co
378
D.E. Shaw & Co
New York
$1.15M +$1.08M +38,997 New
SIM
379
Sentry Investment Management
Wisconsin
$1.14M
EP
380
Edgestream Partners
New Jersey
$1.13M +$1.06M +38,379 New
BCM
381
Barometer Capital Management
Ontario, Canada
$1.11M +$1.04M +37,800 New
CIM
382
Calvert Investment Management
Maryland
$1.11M +$40.9K +1,482 +4%
MC
383
Montag & Caldwell
Georgia
$1.07M +$472K +17,103 +88%
Cambridge Investment Research Advisors
384
Cambridge Investment Research Advisors
Iowa
$1.07M +$264K +9,555 +36%
Northwestern Mutual Wealth Management
385
Northwestern Mutual Wealth Management
Wisconsin
$1M -$4.41M -159,834 -84%
GL
386
GLG LLC
New York
$999K -$166K -6,024 -15%
NB
387
Norinchukin Bank
Japan
$971K +$77.5K +2,808 +9%
TC
388
Telemus Capital
Michigan
$970K +$911K +33,000 New
BCM
389
Bluefin Capital Management
New York
$965K +$906K +32,829 New
NRS
390
Neville Rodie & Shaw
New York
$960K
PAG
391
Private Advisor Group
New Jersey
$953K -$2.86M -103,668 -76%
SCM
392
Shelton Capital Management
Colorado
$936K +$356K +12,900 +68%
BF
393
BOK Financial
Oklahoma
$928K -$202K -7,320 -19%
SLI
394
Sumitomo Life Insurance
Japan
$897K -$15.3K -555 -2%
PA
395
Profund Advisors
Maryland
$893K -$166K -6,015 -17%
FWCM
396
Ferguson Wellman Capital Management
Oregon
$893K
Nordea Investment Management
397
Nordea Investment Management
Sweden
$890K +$281K +10,197 +51%
RJT
398
Raymond James Trust
Florida
$887K -$16.6K -600 -2%
DC
399
Deere & Company
Illinois
$883K -$994K -36,018 -55%
AI
400
Analytic Investors
California
$877K -$17.1M -618,198 -95%

EW Hedge Fund Activity: Q1 2016 in Review

658 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q1 2016, worth a combined $15.9B — down 6.2% from $16.9B a quarter earlier.

Buyers outnumbered sellers: 102 funds opened new EW positions and 39 closed out — a net gain of 63 holders — while 220 added to existing stakes and 243 trimmed.

The largest buyer was Royal London Asset Management, adding an estimated $378M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $2.46B sold.

  • 658 institutional investors held Edwards Lifesciences (EW) as of Q1 2016, up from 604 in Q4 2015.
  • Funds reported $15.9B of Edwards Lifesciences stock for Q1 2016, down 6.2% quarter-over-quarter.
  • 102 funds opened new Edwards Lifesciences positions in Q1 2016 and 39 closed out, a net change of +63 holders.
  • The largest Edwards Lifesciences buyer in Q1 2016 was Royal London Asset Management, an estimated $378M added.
  • The largest Edwards Lifesciences seller in Q1 2016 was Americafirst Capital Management, an estimated $2.46B sold.

Based on aggregated 13F filings for Q1 2016.